Journal of the American Society of Nephrology, Vol 6, 1476-1481, Copyright © 1995 by American Society of Nephrology

REGULAR ARTICLES

Endothelin modulates the pressor actions of acute systemic nitric oxide blockade

C Qiu, K Engels and C Baylis
Department of Physiology, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown 26506-9229, USA.

Acute nitric oxide blockade not only potentiates the vasoconstrictor actions of endothelin but also enhances the synthesis and release of endothelin. To investigate whether the vasoconstrictor actions of acute nitric oxide blockade are modulated by endothelin, studies were conducted in the conscious, chronically catheterized rat. Renal function was measured before and during acute nitric oxide blockade with nitro-L-arginine methylester (L-NAME), L-NAME + endothelin blockade with the endothelin-converting enzyme inhibitor phosphoramidon, or L-NAME + the nonpeptide ETA and ETB receptor antagonist Bosentan. The increases in blood pressure and RVR seen with acute nitric oxide blockade were attenuated by either method of concomitant endothelin blockade. The falls in RPF and GFR were not blunted because endothelin blockade produced parallel reductions of both pressor and renal vasoconstrictor responses to acute nitric oxide blockade. Endothelin blockade alone with either endothelin-converting enzyme inhibitor or the nonpeptide ETA and ETB receptor antagonist had little effect on blood pressure, RPF, or RVR, but increases in urinary sodium excretion and a small decline in GFR were observed with Bosentan. These observations indicate that endogenous endothelin exerts a tonic antinatriuretic action in the normal conscious rat and partially mediates the pressor actions of acute nitric oxide blockade.

This article has been cited by other articles:

				Z. Miloradovic, M. Jerkic, D. Jovovic, N. Mihailovic-Stanojevic, J. G. Milanovic, G. Stosic, and J. Markovic-Lipkovski Bosentan and losartan ameliorate acute renal failure associated with mild but not strong NO blockade Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2476 - 2484. [Abstract] [Full Text] [PDF]

				F. Vargas, J. M. Moreno, R. Wangensteen, I. Rodriguez-Gomez, and J. Garcia-Estan The endocrine system in chronic nitric oxide deficiency Eur. J. Endocrinol., January 1, 2007; 156(1): 1 - 12. [Abstract] [Full Text] [PDF]

				M. Clozel, P. Hess, C. Qiu, S.-S. Ding, and M. Rey The Urotensin-II Receptor Antagonist Palosuran Improves Pancreatic and Renal Function in Diabetic Rats J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1115 - 1121. [Abstract] [Full Text] [PDF]

				A. Tendron-Franzin, J.-B. Gouyon, J.-P. Guignard, S. Decramer, E. Justrabo, T. Gilbert, and D. Salomon Semama Long-Term Effects of In Utero Exposure to Cyclosporin A on Renal Function in the Rabbit J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2687 - 2693. [Abstract] [Full Text] [PDF]

				K. P. Conrad and J. Novak Emerging role of relaxin in renal and cardiovascular function Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261. [Abstract] [Full Text] [PDF]

				S.-S. Ding, C. Qiu, P. Hess, J.-F. Xi, J.-P. Clozel, and M. Clozel Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure Cardiovasc Res, March 1, 2002; 53(4): 963 - 970. [Abstract] [Full Text] [PDF]

				C. E. King-VanVlack, J. D. Mewburn, C. K. Chapler, and P. H. MacDonald Endothelial modulation of skeletal muscle blood flow and VO2 during low- and high-intensity contractions J Appl Physiol, February 1, 2002; 92(2): 461 - 468. [Abstract] [Full Text] [PDF]

				A. Riggleman, J. Harvey, and C. Baylis Endothelin Mediates Some of the Renal Actions of Acutely Administered Angiotensin II Hypertension, July 1, 2001; 38(1): 105 - 109. [Abstract] [Full Text] [PDF]

				S. Xiao, A. Erdely, L. Wagner, and C. Baylis Uremic levels of BUN do not cause nitric oxide deficiency in rats with normal renal function Am J Physiol Renal Physiol, June 1, 2001; 280(6): F996 - F1000. [Abstract] [Full Text] [PDF]

				A. Cases, J. Haas, J. C. Burnett, and J. C. Romero Hemodynamic and renal effects of acute and progressive nitric oxide synthesis inhibition in anesthetized dogs Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R143 - R148. [Abstract] [Full Text] [PDF]

				J. C. Romero and J. F. Reckelhoff Role of Angiotensin and Oxidative Stress in Essential Hypertension Hypertension, October 1, 1999; 34(4): 943 - 949. [Abstract] [Full Text] [PDF]

				X.-Z. Zhang and C. Baylis Endothelin mediates renal vascular memory of a transient rise in perfusion pressure due to NOS inhibition Am J Physiol Renal Physiol, April 1, 1999; 276(4): F629 - F634. [Abstract] [Full Text] [PDF]

				C. Baylis, J. Harvey, B. R. Santmyire, and K. Engels Pressor and Renal Vasoconstrictor Responses to Acute Systemic Nitric Oxide Synthesis Inhibition Are Independent of the Sympathetic Nervous System and Angiotensin II J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 693 - 698. [Abstract] [Full Text]

				R. Zatz and C. Baylis Chronic Nitric Oxide Inhibition Model Six Years On Hypertension, December 1, 1998; 32(6): 958 - 964. [Full Text] [PDF]

				P. Moreau Endothelin in hypertension: A role for receptor antagonists? Cardiovasc Res, September 1, 1998; 39(3): 534 - 542. [Abstract] [Full Text] [PDF]

				J. D. Krier and J. C. Romero Systemic inhibition of nitric oxide and prostaglandins in volume-induced natriuresis and hypertension Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R175 - R180. [Abstract] [Full Text] [PDF]

				J. G. Filep Endogenous Endothelin Modulates Blood Pressure, Plasma Volume, and Albumin Escape After Systemic Nitric Oxide Blockade Hypertension, July 1, 1997; 30(1): 22 - 28. [Abstract] [Full Text]

				P. Moreau, H. Takase, C. F. Kung, S. Shaw, and T. F. Luscher Blood Pressure and Vascular Effects of Endothelin Blockade in Chronic Nitric Oxide–Deficient Hypertension Hypertension, March 1, 1997; 29(3): 763 - 769. [Abstract] [Full Text]

				R. Kramp, P. Fourmanoir, and N. Caron Endothelin resets renal blood flow autoregulatory efficiency during acute blockade of NO in the rat Am J Physiol Renal Physiol, December 1, 2001; 281(6): F1132 - F1140. [Abstract] [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673